Psma

Edit

PSMA: Israel killed 1,012 athletes and sports workers in Gaza genocide

PIC 04 Jul 2026

The secretary-general of the Palestinian Sports Media Association (PSMA), Mustafa Siyam, said the Israeli occupation army has killed around 1,012 Palestinians from Gaza’s sports, youth and scouting ...

Edit

PSMA holds general body meeting

Urdu Point 02 Jul 2026

LAHORE, (APP - UrduPoint / Pakistan Point News - 2nd Jul, 2026) Pakistan Sugar Mills Association (PSMA-North Zone) here Wednesday held its general body meeting presided over by the North Zone Chairman Chaudhry Muhammad Aslam.

Edit

PSMA-Targeted Therapies Market is Projected to Witness Significant Growth by 2036 Owing to the Launch ...

GetNews 30 Jun 2026

PLUVICTO became the first FDA-approved PSMA-targeted therapy for PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) in 2022 and achieved approximately USD 1.4 billion in global revenue during 2024 ... 177Lu-PSMA-I&T (Curium).

Edit

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T ...

Killeen Daily Herald 11 Jun 2026

Completion of patient dosing in the registrational Phase 2 clinical trial for 64Cu-PSMA-I&T - a PET ....

Edit

PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T ...

Caledonian Record 11 Jun 2026

KAWASAKI, Japan--(BUSINESS WIRE)--Jun 11, 2026-- ....

Edit

RadioMedix Announces Receiving FDA Approval of its Generic Ga-68 PSMA-11 Radiodiagnostic for Prostate Cancer

Nasdaq Globe Newswire 10 Jun 2026

Approval follows FDA inspection of RadioMedix’s manufacturing site with no ...

Edit

MOF-UN FAO Joint Hosting of Event Commemorating the 10th Anniversary of Entry into Force of the Port State Measures Agreement (PSMA) in Jeju (Ministry of Trade, Industry and Energy of the Republic of Korea)

Public Technologies 04 Jun 2026

). The text version of this document is not available ... Attachments Original document Permalink. Disclaimer.

Edit

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)

Nasdaq Globe Newswire 26 May 2026

Leading particle accelerator company expands portfolio of positron emission tomography diagnostics ... .

Edit

Convergent Therapeutics to Present Largest Set of Prospective Phase 2 Data for an Alpha Radiopharmaceutical in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer at ASCO 2026

Pharmiweb 22 May 2026

... 2 trial of Ac-225 rosopatamab tetraxetan (CONV01-α) in patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously received Lu-177-PSMA radioligand therapy (Lu-PSMA).

Edit

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer

Caledonian Record 15 May 2026

Telix to partner with companies developing advanced minimally ...

Edit

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

Nasdaq Globe Newswire 15 May 2026

MELBOURNE, Australia and INDIANAPOLIS, May 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX. TLX, NASDAQ ... (NASDAQ ... (NASDAQ. PROF, TSX ... .

Edit

PSMA-Targeted Therapy & Radiodiagnostics Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase ...

Nasdaq Globe Newswire 14 May 2026

The main market opportunities lie in PSMA-targeted therapies and radiodiagnostics, which are proving commercially successful ...

Edit

Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring (Form 8-K) (Profound Medical Corp)

Public Technologies 14 May 2026

Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring ... The Potential Role of PSMA Pet Imaging in iMRI Prostate Ablation.

Edit

How Preclinical PDX Studies Help Guide PSMA Radioligand Development (Champions Oncology Inc)

Public Technologies 12 May 2026

For PSMA-targeted radioligand therapies to reach their full potential, developers need preclinical models that reliably capture both tumor complexity and biodistribution behavior [...].

Edit

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer (Telix Pharmaceuticals Ltd)

Public Technologies 30 Apr 2026

) OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer ... TLX597-Tx is a PSMA[1]-targeting small molecule radioligand therapy ...

Podcasts:

Latest News for: psma

PSMA: Israel killed 1,012 athletes and sports workers in Gaza genocide

PSMA holds general body meeting

PSMA-Targeted Therapies Market is Projected to Witness Significant Growth by 2036 Owing to the Launch ...

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T ...

PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T ...

RadioMedix Announces Receiving FDA Approval of its Generic Ga-68 PSMA-11 Radiodiagnostic for Prostate Cancer

MOF-UN FAO Joint Hosting of Event Commemorating the 10th Anniversary of Entry into Force of the Port State Measures Agreement (PSMA) in Jeju (Ministry of Trade, Industry and Energy of the Republic of Korea)

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)

Convergent Therapeutics to Present Largest Set of Prospective Phase 2 Data for an Alpha Radiopharmaceutical in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer at ASCO 2026

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

PSMA-Targeted Therapy & Radiodiagnostics Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase ...

Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring (Form 8-K) (Profound Medical Corp)

How Preclinical PDX Studies Help Guide PSMA Radioligand Development (Champions Oncology Inc)

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer (Telix Pharmaceuticals Ltd)

Article Search

EXPLORE WN.com